FDA Inspection 1228634 - Novartis Gene Therapies Inc. - January 26, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Novartis Gene Therapies Inc.

Record Details

This FDA Inspection record concerns Novartis Gene Therapies Inc., with an inspection on January 26, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Novartis Gene Therapies Inc.
Inspection Date: January 26, 2024
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · ab2c39ea-5177-471e-8597-985d34d47929

Violation Codes2

21 CFR 211.19221 CFR 600.14(c)

Full citation text and observation details available on the Dashboard.